Neuropathologic Findings in a Child with a Novel Variant of TBCK-Related Encephaloneuronopathy

Abstract

A 3-year-old girl with developmental delays, hypotonia, and generalized seizures was diagnosed with a novel variant of a heterozygous mutation in the TBC1 domain containing kinase (TBCK) gene. Postmortem findings revealed severe hypotrophy of cerebral white matter, hypogenesis of the corpus callosum with reduced myelination and oligodendrocyte populations, and reactive gliosis, and venous angiomas of the cerebrum, brainstem, and cerebellum white matter. This report is the first to link a TBCK gene mutation to impaired white matter development with the targeting of central nervous system myelin and oligodendrocytes. The mechanism may involve inhibition of signaling through (mTORC1).

Keywords

TBCK - brain pathology - cerebral white matter

• References

• 1 Ortiz-González XR, Tintos-Hernández JA, Keller K. , et al. Homozygous boricua TBCK mutation causes neurodegeneration and aberrant autophagy. Ann Neurol 2018; 83 (01) 153-165
• 2 Bhoj EJ, Li D, Harr M. , et al. Mutations in TBCK, encoding TBC1-domain-containing kinase, lead to a recognizable syndrome of intellectual disability and hypotonia. Am J Hum Genet 2016; 98 (04) 782-788
• 3 Liu Y, Yan X, Zhou T. TBCK influences cell proliferation, cell size and mTOR signaling pathway. PLoS One 2013; 8 (08) e71349
• 4 Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell 2012; 149 (02) 274-293
• 5 Chong JX, Caputo V, Phelps IG. , et al; University of Washington Center for Mendelian Genomics. Recessive inactivating mutations in TBCK, encoding a rab GTPase-activating protein, cause severe infantile syndromic encephalopathy. Am J Hum Genet 2016; 98 (04) 772-781
• 6 Dubois J, Dehaene-Lambertz G, Kulikova S, Poupon C, Hüppi PS, Hertz-Pannier L. The early development of brain white matter: a review of imaging studies in fetuses, newborns and infants. Neuroscience 2014; 276: 48-71
• 7 Hirose M, Haginoya K, Yokoyama H. , et al. Progressive atrophy of the cerebrum in 2 Japanese sisters with microcephaly with simplified gyri and enlarged extraaxial space. Neuropediatrics 2011; 42 (04) 163-166
• 8 Lammens M. Neuronal migration disorders in man. Eur J Morphol 2000; 38 (05) 327-333
• 9 Reed UC, Marie SK, Vainzof M. , et al. Heterogeneity of classic congenital muscular dystrophy with involvement of the central nervous system: report of five atypical cases. J Child Neurol 2000; 15 (03) 172-178
• 10 Zimmer A, Hagen T, Ahlhelm F, Viera J, Reith W, Schulte-Altedorneburg G. [Developmental venous anomaly (DVA)]. Radiologe 2007; 47 (10) 868 , 870–874
• 11 Lonjon M, Roche JL, George B. , et al. [Intracranial cavernoma. 30 cases]. Presse Med 1993; 22 (21) 990-994
• 12 Figlia G, Norrmén C, Pereira JA, Gerber D, Suter U. Dual function of the PI3K-Akt-mTORC1 axis in myelination of the peripheral nervous system. eLife 2017; 6: 6
• 13 Figlia G, Gerber D, Suter U. Myelination and mTOR. Glia 2018; 66 (04) 693-707
• 14 Pignataro G, Capone D, Polichetti G. , et al. Neuroprotective, immunosuppressant and antineoplastic properties of mTOR inhibitors: current and emerging therapeutic options. Curr Opin Pharmacol 2011; 11 (04) 378-394
• 15 Yoon MS. The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling. Nutrients 2017; 9 (11) E1176
• 16 Narayanan SP, Flores AI, Wang F, Macklin WB. Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination. J Neurosci 2009; 29 (21) 6860-6870